v3.24.2.u1
PRODUCT REVENUE, NET (Tables)
6 Months Ended
Jun. 30, 2024
PRODUCT REVENUE, NET  
Schedule of product revenue by geographic location

The Company’s product revenue, net was generated from sales of DANYELZA and consists of the following (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended June 30, 

​

Six months ended June 30, 

​

    

2024

​

2023

    

2024

​

2023

​

​

(in thousands)

Product revenue, net by geographical location:

​

​

​

​

​

​

​

​

​

​

​

​

United States

​

$

15,226

​

$

15,851

​

$

33,836

​

$

32,685

International:

​

​

​

​

​

​

​

​

​

​

​

​

Western Europe

​

​

2,076

​

​

—

​

​

2,076

​

​

2,516

Eastern Asia

​

​

3,415

​

​

4,553

​

​

3,466

​

​

5,304

Latin America

​

​

1,749

​

​

—

​

​

2,257

​

​

—

Other regions

​

​

332

​

​

347

​

​

594

​

​

497

Total international

​

​

7,572

​

​

4,900

​

​

8,393

​

​

8,317

Total product revenue, net

​

$

22,798

​

$

20,751

​

$

42,229

​

$

41,002

Schedule of product sales to certain customers that accounted for more than 10% of total product revenue, net

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended June 30, 

​

Six months ended June 30, 

​

    

2024

​

2023

    

2024

​

2023

​

​

​

McKesson

​

38

%

​

46

%

​

43

%

​

44

%

Cardinal Health

​

18

​

​

12

​

​

19

​

​

12

​

AmerisouceBergen

​

11

​

​

18

​

​

17

​

​

23

​

SciClone

​

15

​

​

20

​

​

8

​

​

12

​

Schedule of change in reserves for discounts and allowances

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

Contractual

 

    

​

​

    

​

​

​

​

​

Allowances and

​

​

​

​

​

​

​

Discounts

​

Government Rebates

 

Returns

​

Total

​

​

Balance December 31, 2023

$

41

​

$

2,694

​

$

66

​

$

2,801

Current provisions relating to sales in current year

​

187

​

​

5,223

​

​

7

​

​

5,417

Payments/credits relating to sales in current year

​

(156)

​

​

(5,386)

​

​

—

​

​

(5,542)

Change in estimate related to sales in the prior year

​

—

​

​

(382)

​

​

—

​

​

(382)

Balance June 30, 2024

$

72

​

$

2,149

​

$

73

​

$

2,294

​